Metaphore Biotechnologies: Funding, Investors & Team (Oct 2026)
Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential of functional molecular mimics. The MIMiCTM platform, developed by the business, is a computationally driven bio platform for developing novel therapies in which function, specificity, and selectivity may be optimized. Metaphore is dedicated to uncovering previously inaccessible pharmacological targets and achieving breakthroughs that exceed today's medications for maximum patient effect.
Metaphore Biotechnologies has raised $50.0M across 3 funding rounds on record, the most recent an undisclosed round announced in Aug 2026.
Metaphore Biotechnologies Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Metaphore Biotechnologies Funding Rounds
2 of 3 rounds were announced without a disclosed amount and are excluded from the total.
Metaphore Biotechnologies raised $50.0M in an undisclosed round announced in May 2023.
2.9 years later, an undisclosed round was announced in Apr 2026 with no disclosed amount.
4 months later, an undisclosed round was announced in Aug 2026 with no disclosed amount.
Metaphore Biotechnologies Investors
Metaphore Biotechnologies Founders and Leadership Team
Contact details for the Metaphore Biotechnologies team: 2 of 4 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Metaphore Biotechnologies Funding Compared to Other Biotechnology Startups
Funded Startups Like Metaphore Biotechnologies in Biotechnology and Cambridge
Companies Similar to Metaphore Biotechnologies
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Metaphore Biotechnologies Funding FAQs
What does Metaphore Biotechnologies do?
Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential of functional molecular mimics. The MIMiCTM platform, developed by the business, is a computationally driven bio platform for developing novel therapies in which function, specificity, and selectivity may be optimized. Metaphore is dedicated to uncovering previously inaccessible pharmacological targets and achieving breakthroughs that exceed today's medications for maximum patient effect.
How much funding has Metaphore Biotechnologies raised?
Metaphore Biotechnologies has raised $50.0M across 3 rounds on record.
When did Metaphore Biotechnologies last raise funding?
Metaphore Biotechnologies' most recent funding round on record was announced in Aug 2026. The amount was not disclosed.
Who has invested in Metaphore Biotechnologies?
Investors on record for Metaphore Biotechnologies include Global Brain Corporation, Flagship Pioneering, LOTTE HB, TOHO Ventures.
Who founded Metaphore Biotechnologies?
FundedIQ lists Angela Hwang (Founder), Fionna Surette (Founder) at Metaphore Biotechnologies.
Where is Metaphore Biotechnologies headquartered?
Metaphore Biotechnologies is based in Cambridge, Massachusetts, United States.
How many employees does Metaphore Biotechnologies have?
Metaphore Biotechnologies is in the 11-50 employee band.
When was Metaphore Biotechnologies founded?
Metaphore Biotechnologies was founded in 2021.
About FundedIQ's Metaphore Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Metaphore Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.